Executive Summary

Oct 2019
PROSPECTS
Climate change, urbanisation and pollution drive growth

Cough, cold and allergy (hay fever) remedies is expected to generate healthy value growth over the forecast period. This is due to the projected decline in air quality in addition to climate change and pollution in Tunisia.

Increased allergies result in positive value sales

Allergies are increasing in Tunisia, with trade sources recording 500,000 cases and numbers only expected to increase over the forecast period. One of the main triggers for allergies is the increasing urbanisation and environmental pollution, particularly in big cities such as Tunis and Sfax.

Product variation results in a strong performance over the forecast period

The value CAGR for cough, cold and allergy (hay fever) remedies over the forecast period will be faster compared to that of the review period at current 2019 prices. More dynamic economic activity will positively impact sales, given its high correlation coefficient to GDP performance.

COMPETITIVE LANDSCAPE
Domestic manufacturers lead the competitive landscape

Domestic companies maintained control of cough, cold and allergy (hay fever) remedies in Tunisia in 2019, including Sanofi-Aventis Pharma Tunisie, and Bristol-Myers Squibb UPSA Tunisie. Domestic players offer very affordable products and are generally well regarded by Tunisian consumers in terms of effectiveness.

Advertising through French television continues to aid sales

Advertising of cough and cold items tends to be intense prior to and during the winter, while allergy remedies are mostly advertised in spring and summer. However, advertising remained banned in Tunisia in 2019, meaning cough, cold and allergy (hay fever) remedies were not permitted to launch advertising activity across above-the-line channels.

Global players compete in cough, cold and allergy (hay fever)

Major players such as Rhinostop and Dolirhume remain popular in Tunisia, due to their widespread availability and low prices compared to imported goods. However, a wide range of global offerings will continue to compete within cough, cold and allergy (hay fever) remedies such as Fervex and Pectol.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Cough, Cold and Allergy (Hay Fever) Remedies in Tunisia

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Tunisia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Tunisia, our research will save you time and money while empowering you to make informed, profitable decisions.

The Cough, Cold and Allergy (Hay Fever) Remedies in Tunisia market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in Tunisia?
  • What are the major brands in Tunisia?
  • What is the impact of influenza vaccinations on the sales of cough and cold products?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Cough, Cold and Allergy (Hay Fever) Remedies in Tunisia - Category analysis

HEADLINES

PROSPECTS

Climate change, urbanisation and pollution drive growth
Increased allergies result in positive value sales
Product variation results in a strong performance over the forecast period

COMPETITIVE LANDSCAPE

Domestic manufacturers lead the competitive landscape
Advertising through French television continues to aid sales
Global players compete in cough, cold and allergy (hay fever)

CATEGORY DATA

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2014-2019
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2019
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2019
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024

Consumer Health in Tunisia - Industry Overview

EXECUTIVE SUMMARY

A low supply of medication and health and wellbeing shaped consumer health
Steady growth for most of consumer health as Tunisians self-medicate
Threats to consumer health include the advertising ban and illegal products
Most consumer healthcare products are purchased in chemists/pharmacies
Positive results will be sustained across the forecast period

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Distribution of Consumer Health by Format: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format and Category: % Value 2019
Table 15 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches

DEFINITIONS

SOURCES

Summary 1 Research Sources